Clarithromycin should be used in pregnancy only when the expected benefit justifies any potential risk to the fetus. Clinical data are limited, so healthcare providers usually reserve it for infections where safer alternatives are unsuitable.
The drug’s half-life is approximately 3-7 hours, but active metabolites may persist longer. Most of the medication is eliminated within 24 hours after the last dose.
Yes. Clarithromycin can increase the blood levels of certain statins (especially simvastatin and lovastatin), raising the risk of muscle toxicity. Your prescriber may lower the statin dose or select an alternative lipid-lowering agent.
Taking clarithromycin with a meal improves its absorption and reduces gastrointestinal side effects, so it is recommended.
Occasional moderate alcohol consumption is generally acceptable, but heavy drinking can increase liver strain. Discuss your alcohol intake with your healthcare provider.
Clarithromycin is not known to trigger false positives on standard workplace drug screens for substances such as cannabinoids or opioids.
Severe or watery diarrhoea may indicate Clostridioides difficile infection. Contact your healthcare provider promptly; treatment may require discontinuation of the antibiotic and specific therapy for C. difficile.
Both are macrolides, but clarithromycin generally has a longer half-life and stronger activity against Haemophilus influenzae, whereas azithromycin is often favoured for its once-daily dosing and lower drug-interaction potential.
If a sore throat is caused by a bacterial infection such as streptococcal pharyngitis, clarithromycin may be prescribed, especially in patients allergic to penicillins. Viral sore throats do not benefit from antibiotics.
Do not keep unused medication for future illnesses. Dispose of leftover tablets according to local pharmacy take-back programmes or follow the UK NHS guidelines for safe disposal of medicines.
Clarithromycin is an oral antibiotic belonging to the macrolide class. It is available in pill form in strengths of 250 mg and 500 mg. In the United Kingdom, clarithromycin is a prescription-only medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Numerous manufacturers produce clarithromycin tablets, and the drug is commonly prescribed for a range of bacterial infections.
Clarithromycin exerts its antibacterial effect by binding to the 50 S subunit of bacterial ribosomes. This interferes with the translocation step of protein synthesis, preventing the bacteria from producing essential proteins required for growth. At standard therapeutic concentrations the drug is bacteriostatic (it halts bacterial replication), but at higher concentrations it can become bactericidal against certain organisms. Clarithromycin is absorbed well from the gastrointestinal tract, especially when taken with food, and reaches peak plasma levels within 2-3 hours. It is extensively metabolised in the liver via the CYP3A4 enzyme and is eliminated mainly in the bile.
Clarithromycin is authorised in the UK for the following indications, reflecting guidance from the National Institute for Health and Care Excellence (NICE) and the Summary of Product Characteristics (SmPC):
These approved uses are based on clinical trials demonstrating efficacy against common respiratory, skin, and gastrointestinal pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus (including some macrolide-sensitive strains), and Mycobacterium species.
Some clinicians prescribe clarithromycin for conditions that are not formally approved but have supporting research:
Disclaimer: Off-label use of clarithromycin requires careful medical supervision, individualized risk assessment, and adherence to local prescribing policies.
These effects are usually transient and resolve without intervention.
Dosage should be tailored by the prescriber based on infection severity, susceptibility patterns, and patient factors.
If a dose is missed, take it as soon as you remember unless it is almost time for the next scheduled dose. Do not double the dose to compensate.
Symptoms may include nausea, vomiting, abdominal pain, and abnormal heart rhythms. Seek immediate medical attention; activated charcoal may be considered if presentation is early. There is no specific antidote.
Clarithromycin does not usually require tapering. However, abrupt cessation after prolonged therapy for atypical infections (e.g., MAC) should be guided by the treating physician to avoid relapse.
This article provides educational information about clarithromycin and is not a substitute for professional medical advice. Treatment decisions, including the use of clarithromycin for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
